Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>News>This Article

New Targeted Approach to Light-Activated Cancer Drugs

Published: Monday, November 12, 2007
Last Updated: Monday, November 12, 2007
Bookmark and Share
Combining light-activated cancer drugs with tumor-seeking antibodies could provide a more effective way of treating many cancers, according to new research.

Combining light-activated cancer drugs with tumor-seeking antibodies could provide a more effective way of treating many cancers, according to new research published in advance online in the International Journal of Cancer.

The study, which is due to appear in the December issue of the journal, describes how scientists have attached 10 light-activated drug molecules to an antibody which recognizes and homes in on the cancerous cells.

The researchers have shown that using this method means highly potent drug molecules are delivered to precise cancer targets much more effectively than if they are not attached to the antibody.

Using light-activated drugs to treat cancer is known as photodynamic therapy (PDT). This treatment involves focusing drugs on diseased tissues, and then illuminating the area with a cold laser which sets off a chain reaction in the cancerous tissue, converting oxygen to a highly toxic type of oxygen-like bleach, which destroys cells in the vicinity.

PDT has been shown to be successful in treating head and neck, prostate and skin cancers.

However, current PDT is limited by the inefficiency with which the light-activated drugs are able to specifically target tumors. This can mean that the light-activated drugs can circulate in the patient's body for some time after the treatment, leaving patients light-sensitive and prone to skin damage. The research team behind the new study thinks their results show they can solve this problem by ensuring the drugs get straight to the cancerous cells, and do not affect the rest of the body.

Dr Mahendra Deonarain from Imperial College London's Department of Life Sciences, lead author on the paper, explains: "PDT is a very promising way to treat cancer because it leaves patients with very little cosmetic scarring and there are low chances of drug resistance. We have shown that it's possible to use tumor-seeking antibodies, like the ones used in drugs like Herceptin and Rituxan, to deliver these potent drugs accurately to the site of the cancer, minimizing the risk of healthy tissue getting accidentally damaged in the treatment process, and maximizing the number of cancer cells that are destroyed."

The research team, led by scientists from Imperial and the Imperial spin-out company PhotoBiotics, has shown that their antibody-carrying light-sensitive drugs have effected complete tumor regression in an animal model.

Dr Deonarain explains that the next step is to take the study forward into clinical trials: "We have shown that it's possible to attach these drug molecules to these targeting antibodies without destroying the useful properties of the antibody itself. Our initial results are extremely promising and we're hoping to take this forward into clinical trials in the near future. Our work is expanding the applications of PDT for many cancers and we're excited about moving towards making targeted PDT a clinical reality."

PhotoBiotics has 4 filed patents protecting this new technology and is currently completing further pre-clinical studies with a view to moving into clinical trials within the next three years

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Breakthrough Could Lead to New Antibiotics
Scientists have exposed a chink in the armour of disease-causing bugs, with a new discovery about a protein that controls bacterial defences.
Friday, August 21, 2015
New Drug Target Identified for Serious Heart and Lung Condition
A gene has been identified that sheds new light on a potentially fatal heart and lung condition and could lead to a new treatment.
Friday, August 14, 2015
New Genetic Form of Obesity and Diabetes Discovered
Scientists have discovered a new inherited form of obesity and type 2 diabetes in humans.
Tuesday, June 30, 2015
New Genetic Form of Obesity and Diabetes Discovered
Scientists have discovered a new inherited form of obesity and type 2 diabetes in humans.
Tuesday, June 30, 2015
New 'Systems Genetics' Study Identifies Possible Target For Epilepsy Treatment
A single gene that coordinates a network of about 400 genes involved in epilepsy could be a target for new treatments, according to research.
Friday, January 23, 2015
Biomarker Discovery Sheds New Light on Heart Attack Risk of Arthritis Drugs
Drug may be given a new lease of life.
Thursday, December 11, 2014
Genetic Discovery Could Aid Diagnosis of Childhood TB
A distinctive genetic 'signature' found in the blood of children with TB offers new hope for improved diagnosis of the disease.
Thursday, May 01, 2014
Body Clock Receptor Linked to Diabetes in New Genetic Study
Study found that people who carry rare genetic mutations in the receptor for melatonin have higher risk of type 2 diabetes.
Tuesday, January 31, 2012
New Technology Could Slash Sequencing Time
Scientists from Imperial College London are developing technology that could ultimately sequence a person's genome in mere minutes, at a fraction of the cost of current commercial techniques.
Monday, December 20, 2010
Swine Flu: Early Findings about Pandemic Potential Reported in new Study
Early findings about the emerging pandemic of a new strain of influenza A (H1N1) in Mexico published in Science.
Tuesday, May 12, 2009
Study Suggests Listening to Pleasant Music Could Help Restore Vision in Stroke Patients
Patients who have lost part of their visual awareness following a stroke can show an improved ability to see when they are listening to music they like, according to a new study published in the journal Proceedings of the National Academy of Sciences.
Tuesday, March 24, 2009
Schizophrenia Linked to Signaling Problems in New Brain Study
The study supports the theory that abnormalities in the way in which cells 'talk' to each other are involved in the disease.
Wednesday, March 04, 2009
HIV Treatment Test Closer to Manufacture with new $7.3 Million Grant
The CD4 Initiative will use the grant received from Bill & Melinda Gates Foundation, to develop a point-of-care test for HIV/AIDS patients.
Wednesday, February 18, 2009
Alzheimer's Disease Patients Show Improvement in Trial of new Drug
A new drug has been shown to improve the brain function of Alzheimer's patients and reduce a key protein associated with the disease in the spinal fluid.
Wednesday, July 30, 2008
Breast Cancer Researchers Call for Ethnicity to be Taken into Account When Developing Treatments
Breast cancer research needs to investigate how a person's ethnicity influences their response to treatment and its outcome, Imperial researchers say.
Monday, July 21, 2008
Scientific News
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Genes That Protect African Children From Developing Malaria Identified
Variations in DNA at a specific location on the genome that protect African children from developing severe malaria, in some cases nearly halving a child’s chance of developing the life-threatening disease, have been identified in the largest genetic association study of malaria to date.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos